Advanced Oncotherapy (AVO) said it had made ‘significant progress’ towards achieving its corporate goals over the last 12 months as it announced results for the…
Technological progress boosts confidence in Advanced Oncotherapy
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
 said it had made ‘significant progress’ towards achieving its corporate goals over the last 12 months as it announced results for the year ended 31 December 2019.){kind=link}